Ablation Technologies Competing for Growing Patient Volume and Penetration of Clinical Practice, According to New MedMarket Diligence Report

Ablation technologies are a growth medtech field driven as much by physicians pursuing larger caseload as manufacturers developing innovative technologies, according to a new global report from MedMarket Diligence.

(PressMethod) – Surgical procedures focus on a wide range of clinical endpoints — the creation of a lesion to block aberrant cardiac rhythms, the destruction of cancerous tissue, the ligation of tissues with associated hemostasis, and many others — which has driven the development of an array of ablation technology types that are now competing aggressively with each other for a growing caseload of procedures. The ablation technologies with some of the most rapidly growing use rates are cryotherapy and radiofrequency ablation, followed by ultrasound, laser and, due to innovations in its implementation, radiotherapy. These are among the findings in a new medical technology report from MedMarket Diligence.

Although the applications of ablation devices include a number of aesthetic treatments, the majority of applications remain chronic disorders in areas which include cancer, cardiovascular, urology, gynecology and orthopedics. Many of these disorders are age-related, and the related device segments are driven by the aging of the global populations. Other market drivers include the Chinese government's push to modernize its healthcare facilities by building 400 hospitals per year, and developed country populations which are demanding anti-aging treatments, to which physicians are responding by purchasing equipment.

"Like the most successful medical technologies, ablation technologies have as their underlying driver for success the ability of physicians to capture greater caseload due to their ability to promote the clinical efficacy of ablation, faster healing times, fewer complications and many other benefits," says Patrick Driscoll, President of MedMarket Diligence. According to Driscoll, the top ablation technologies are growing at nearly 20% annually in manufacturer revenues. These include control systems, instrumentation and probes and other disposables used during the procedures.

The MedMarket Diligence report, "Ablation Technologies Worldwide Market, 2009-2019: Products, Technologies, Markets, Companies and Opportunities", describes alternative energy-based technologies and the nature of their effect on soft tissue, the underlying basis of the technology, the requisite systems for their use (including capital equipment, devices and disposables), and their strengths and weaknesses for specific clinical applications. The report details current and anticipated target applications and assesses the current and forecast caseload for each energy-based therapeutic considering competition from any and all alternative energy-based or other therapeutics, with current and worldwide market forecasts (2009-2019) segmented by technology type and specific clinical segment. The report provides segmentation of the worldwide ablation market by both ablation technology and region/country: Americas (USA, Canada, Mexico, Brazil), Europe (Germany, United Kingdom, France, Italy, Spain, BeNeLux), Asia/Pacific (Japan, China, India, Australia) and Rest of World. The report details the current and emerging products, technologies and markets for each energy-based therapy. The report profiles 76 key companies in this industry detailing their current products, current market position and products under development.

The report is described in detail, including table of contents and list of exhibits, at link. The report may purchased for immediate download at link.

 

Ablation Technologies Market to Reach $10 Billion in 2010, According to a New MedMarket Diligence Report

PRLog (Press Release) – Jun 09, 2010 – The practice of surgery has long employed energy-based technologies to excise, cut, ablate, cauterize, destroy or otherwise manipulate tissue to produce therapeutic results. Various energy modalities — from cryotherapy to microwave to radiofrequency to ultrasound to radiation and others — have proven their ability to effect healthy or diseased tissue with more effective outcomes than other physical methods (e.g., the scalpel) can allow. These effects and outcomes include: 

  • destruction of diseased (e.g., cancerous) tissue preferentially over healthy tissue
  • simultaneous cutting and hemostasis of the surgical wound
  • creating lesions, as in treatment of atrial fibrillation, that block aberrant electrical pathways
  • sculpting of tissue as in laser vision correction
  • a wide range of other applications

The number and diversity of clinical applications in ablation is driven by the diversity of the different energy modalities: 

  • Microwave
  • Ultrasound
  • Electrical
  • Radiation
  • Radiofrequency
  • Hydromechanical
  • Cryotherapy
  • Thermal
  • Light

Products and technologies in ablation include capital equipment, instruments and disposable probes and other products. It is a robust area in which manufacturers aggressively develop and release new product configurations that improve upon patient outcomes and capture growing share of caseload. 

While there is a concentration of some ablation modalities for specific types of treatment (e.g., radiation has long been a predominant treatment in cancer), the modalities that compete with one another for caseload varies considerably from one clinical application to the next.  Therefore, a consideration of the market for any one of these modalities is not complete without also examining the competition presented by other modalities on a case-by-case basis. 

MedMarket Diligence's report (described at http://mediligence.com/rpt/rpt-a145.htm) on the Ablation Technologies Worldwide Market details the global market for ablation technologies, encompassing discussion of the specific tissue effects of each modality, the current and emerging surgical procedures, the products and technologies under development, the growing list of active manufacturers and developers and the worldwide market, by country/region for ablation technologies by modality. 

This 488 page report, with 123 tabular and graphic exhibits, is a detailed market and technology assessment and forecast of the products and technologies in the ablation market for treatment of soft tissues via energy-based modalities, including electrosurgery, radiosurgery, gamma knife, brachytherapy, cryogenic therapy, fluidjet therapy (hydrotherapy), microwave ablation, radiofrequency ablation, laser, thermal ablation, and ultrasonic ablation. 

The report describes alternative energy-based technologies and the nature of their effect on soft tissue, the underlying basis of the technology, the requisite systems for their use (including capital equipment, devices and disposables), and their strengths and weaknesses for specific clinical applications. The report details current and anticipated target applications and assesses the current and forecast caseload for each energy-based therapeutic considering competition from any and all alternative energy-based or other therapeutics, with current and worldwide market forecasts (2009-2019) segmented by technology type and specific clinical segment. The report provides segmentation of the worldwide ablation market by both ablation technology and region/country:Americas (USA, Canada, Mexico, Brazil), Europe (Germany, United Kingdom, France, Italy, Spain, BeNeLux), Asia/Pacific (Japan, China, India, Australia) and Rest of World. The report details the current and emerging products, technologies and markets for each energy-based therapy. The report profiles over 76 key companies in this industry detailing their current products, current market position and products under development.

The report is described in detail at link.  The report may be purchased for immediate download online or may be purchased by order form.


# # #

MedMarket Diligence provides data and insight to the medical products, investment and other industries on © 2018, MedMarket Diligence, LLC -- advanced medical technologies through focused medical technology market and assessment Reports and the Medtech Startups Database.

 

 

 

 

 

 

 

 

Report: Worldwide Tissue Engineering & Cell Therapy Market at $6.9 billion

Our research into the products, technologies, companies and markets for tissue engineering and cell therapy has revealed that the 2009 market was at $6.9 billion. The market has grown dramatically, in commercialized products and company activity, over the past few years and is on an accelerated growth rate as technology hurdles are overcome and clinical acceptance is gained in a wide range of applications spanning cardiology, neurology, orthpedics/musculoskeletal/spine, urology, skin/integumentary, dental/oral, organ replacement and preservation, ophthalmology, general/gastroenterology/gynecology, cancer and cord blood & cell banking.

 

Worldwide Tissue Engineering & Cell Therapy Market, by Segment, 2009

Source: MedMarket Diligence, LLC, Report #S520

The report, described at link, details the activities, products and markets for these applications represented by almost 150 active companies.  The report may be purchased for download at link.  Until February 28, 2010, we're offering 10% off the purchase price of this report. Just order the report online and on checkout enter the coupon code "1266865321" to receive the 10% discount.


Wound Care Markets: Country-Specific Patterns, Drivers, Opportunities

Clinical protocols for the treatment of specific wounds can vary considerably from country to country. Venous stasis ulcers, which account for approximately 4% of wounds and 75% of leg ulcers, are treated with short stretch compression bandages in Germany, elastic adhesive bandages in Italy, high compression bandages in France and multi-layer compression systems in the UK. As in the US, the routine use of strong antiseptics is discouraged in the UK and Germany but still prevalent in East European countries as well as the Netherlands and Italy.

The quest for standardized modern approaches to wound healing is aided by groups such as the European Wound Management Association and European Tissue Repair Society, which encourage pan-European dialogue on issues pertaining to wound care. Such organizations have had significant effect on the development of US wound care policy and practices. 

The proliferation of different wound care products and strategies leads to confusion and uncertainty over the best practice options. Clinical comparisons between treatment modalities have been minimal, with reliance on small, product-focused studies that often omit the wider context under which wounds are treated. Users of wound care products rely on manufacturers for performance data and increasingly turn to the larger manufacturers for staff education and wound care treatment protocols that will naturally include the use of the large number of products in the manufacturer’s line. In many countries in Europe, testing procedures have been developed by government-supported cross-company working panels that meet regularly to define specific protocols for testing products. These tests gradually become adopted by manufacturers as first lines of evaluation for new technologies.

The emerging use of electronic devices for wound documentation and assessment is expected to allow the comparison of large numbers of wounds undergoing different integrated approaches to wound care and begin to differentiate those activities that provide the most benefit to wound healing. As in the rest of the world, studies need to become larger, more standardized and complete to allow scientific comparison of products and practices that include multiple product classes and the management of the underlying conditions that create chronic wounds.

In addition, electronic devices for recording individual patient data are becoming available. These devices are important to ensure continuity of treatment, particularly in the home environment where several visiting nurses may see a single patient over a period of weeks. Without a good monitoring tool a complex and inconsistent mix of products and strategies could be applied.


From MedMarket Diligence Report #S247,  "Worldwide Wound Management, 2008-2017: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World."

Europe’s $1.2 billion wound closure products market

Although market growth in some Eastern European countries that have recently joined the EU is more rapid than in the west, the major European markets in terms of size are still Germany, United Kingdom, France, Italy and Spain. The market for advanced wound closure and securement products is relatively mature in Europe and the scope for vigorous growth is correspondingly lower than in the United States.

With a population of 82 million, Germany is the leading European medical market and the wound closure and securement segment represents almost 6% of the global market, with advanced products in widespread use. One of the main companies in the field, B. Braun, is headquartered here, as is Meyer-Haake (makers of Epiglu); CSL Behring (formerly Aventis-Behring) also has a strong presence. American companies such as Ethicon and Covidien are also well represented.

Source: MedMarket Diligence, LLC; from "Worldwide Surgical Sealants, Glues and Wound Closure, 2009-2013"Report #S175.

Global wound care market segmentation, drivers

Products and technologies used in advanced wound management have found varying degrees of success in global markets, stemming from differences in clinical practices, cultures, sensitivities, demographics and other geographically-driven differences.  At the macro view, the size of the advanced wound management market by countries falls in a typical pattern based on the relative size of the populations and healthcare markets:

world-wound-pie-countries

Source: MedMarket Diligence report #S247

The differences between these markets in their relative adoption and use of advanced wound management technologies is illustrated in the graph below, showing the percent of each country's total market that is represented by each wound product type.

wound-countries-and-segments

Source: MedMarket Diligence report #S247.

 

The size of the wound care market is ultimately determined by the clinical need for advanced wound management products. That need is most clearly reflected in the prevalence of chronic wounds and burns. Current estimates put the total annual incidence of chronic wounds at almost 9 million worldwide, and there are 177 million cases of diabetes worldwide; 10%–15% of diabetic patients will develop ulcers at some point. The market for products used in the management of specific wound types are, in decreasing size, venous stasis (as in chronic venous ulcers) decubitus ulcer (e.g., bedsores), diabetic foot ulcers and lastly (despite their acute nature) burn wonds.

[ad#ad-3]

It should be noted that a large proportion of wound product sales are accounted for by traditional types of wound management products. It has been estimated that two-thirds of the world’s physicians are not making routine use of advanced wound management products. Perhaps surprisingly, U.S. physicians are much more conservative in their approach to advanced wound healing technologies than their European counterparts. For this reason, the European share of the AWC market is significantly higher than the U.S. share.

The implication is that there is significant market potential, if barriers such as cost and entrenched attitudes can be overcome. It is not yet widely appreciated, even in some parts of the developed world, that the relatively high initial cost of managing hard-to-heal wounds with advanced techniques is more than offset by the savings achieved with shorter treatment periods and reduction in the demand for skilled medical attention.

 

(From "Worldwide Wound Management, 2008-2017: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World", report #S247.)